![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 6, 3907-3914, February 11, 2000
From the Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama 35294
| |
ABSTRACT |
|---|
|
|
|---|
The glycosidic linkages of the type 3 capsular
polysaccharide of Streptococcus pneumoniae
([3)- The capsular polysaccharides of Streptococcus
pneumoniae are essential components in virulence that are
necessary to resist host phagocytic mechanisms. So far, ninety
different capsular polysaccharides have been identified (1). The
polymers are usually composed of repeating oligosaccharide subunits
containing several different monosaccharides and, in many cases, are
branched structures (2). In S. pneumoniae, the genes
involved in the biosynthesis of any one capsular polysaccharide are
contained within a single locus on the bacterial chromosome and are
termed "type-specific." Only two type 3-specific genes,
cps3D and cps3S, which encode a UDP-Glc
dehydrogenase and the type 3 synthase, respectively, are essential for
synthesis of the type 3 polysaccharide (3), a linear structure composed
of
[ The type 3 polysaccharide synthase
(Cps3S)1 shares significant
protein homology with several other glycosyltransferases from both
prokaryotes and eukaryotes, including the hyaluronan synthase from
S. pyogenes, the Nod factor oligosaccharide
synthase (NodC) from Rhizobium meliloti, FbfA of
Stigmatella aurantiaca, pDG42 of Xenopus
laevis, and chitin synthases from both Saccharomyces cerevisiae and Candida albicans (3). All of these
enzymes produce homopolymers or polysaccharides with a simple
disaccharide repeat, and current evidence suggests that each is capable
of forming all of the glycosidic linkages present in their respective
polysaccharides (3, 13-21). Hydrophobic cluster analysis of the
deduced sequences of these proteins has revealed two conserved domains
that are believed to be responsible for binding the nucleotide sugars
and catalyzing the formation of the glycosidic linkages (22, 23). Based
on this analysis, it has been proposed that these glycosyltransferases synthesize polysaccharide via a common mechanism that involves dual
addition of sugars to the growing saccharide chain (23).
Smith et al. (24) demonstrated that type 3 synthase activity
resides within the particulate fraction of S. pneumoniae
lysates. Using a type 3-specific antibody to precipitate and quantitate polysaccharide, they observed synthesis of type 3 polysaccharide using
cell-free lysates, uridine nucleotide sugars, and a divalent metal
cation (24). Consistent with the observed membrane location of type 3 synthase activity, the deduced amino acid sequence of Cps3S contains
four hydrophobic domains potentially capable of spanning the membrane
(3). The role of Cps3S as the type 3 synthase was demonstrated using
isogenic strains containing insertion mutations either in or
immediately downstream from cps3S. Type 3 polysaccharide
could be synthesized in the in vitro system using crude
membrane preparations from the latter but not from the former, thus
establishing cps3S as the critical gene (3). Expression of
the synthase in Escherichia coli has proven difficult,
apparently because of toxicity of the membrane protein (3, 13). The only reported clone expressing the enzyme produced low levels of
protein, despite being contained in a high copy number expression vector (13). The possibility of mutations in the clone was not eliminated, but a small amount of type 3 polysaccharide was synthesized in the E. coli strain, further confirming the assignment of
cps3S as the type 3 synthase. Because production of high
levels of synthase from cloned products has not been possible, we chose
to use membranes isolated from S. pneumoniae as a source of
synthase activity for further biochemical studies. Using an assay that
measures the incorporation of radiolabeled sugars into polysaccharide,
we have characterized the mechanism of type 3 polysaccharide synthesis.
Materials--
Mutanolysin, Type VIII-A Bacterial Strains, Growth Conditions, and Enzyme
Preparation--
Membranes containing type 3 synthase were isolated
from S. pneumoniae based on a previously described procedure
(25). The encapsulated type 3 strain WU2 and its nonencapsulated
isogenic derivative JD908, which contains an insertion mutation in
cps3S, have been described (7, 26). A 4-liter culture was
grown at 37 °C in Todd Hewitt Broth supplemented with 0.5% yeast
extract (THY) to a density of 3 × 108 colony forming
units/ml. The cells were collected by centrifugation at 10,000 × g for 20 min. The pellets were washed once in 2 liters of
phosphate-buffered saline (137 mM NaCl, 2.7 mM
KCl, 5.4 mM Na2HPO4·7H20, 1.8 mM
KH2PO4, pH 7.4) and then suspended in 200 ml of
protoplast buffer (20% sucrose, 5 mM Tris-HCl, pH 7.4, and 2.5 mM Mg2S04). Mutanolysin was
added to a final concentration of 20 units/ml, and the mixture was
incubated at room temperature overnight. Protoplast formation was
checked by examining the cells using a phase contrast light microscope.
The protoplasts were sedimented by centrifugation at 25,000 × g for 20 min, washed once in 200 ml of protoplast buffer,
and then osmotically lysed by suspension in 100 ml of sterile water
containing 10 mM EDTA. Lysis was confirmed by light
microscopy. The membranes were collected by centrifugation at
100,000 × g for 30 min, washed three times in 40 ml of
100 mM Hepes (pH 8.0) buffer containing 10 mM
sodium thioglycolate, and suspended in 15 ml of the same buffer. The final membrane preparation was adjusted to 3 mg protein/ml in 100 mM Hepes (pH 8.0) buffer containing 10 mM
sodium thioglycolate and stored at Assay of Synthase Activity--
Type 3 synthase activity was
determined by the incorporation of 14C label from either
UDP-[14C]Glc or UDP-[14C]GlcUA into
polysaccharide. Synthase assays were performed in a 100-µl reaction
that contained 100 mM Hepes (pH 8), 10 mM
sodium thioglycolate, 10 mM MnCl2, UDP-Glc,
UDP-GlcUA, and membranes isolated as described above. The
concentrations of UDP-Glc, UDP-GlcUA, and membrane protein are
indicated elsewhere in the text and in the figure legends. The reaction
mixtures were incubated at 32 °C for 20 min. The reaction was
terminated by addition of 10 µl of 12.5 M glacial acetic
acid, and the reaction components were separated by ascending paper
chromatography on 3 MM Whatman paper in ethanol (95%):1 M
ammonium acetate (pH 7.0), 7:3 (v/v) for 16-18 h. The chromatograms
were dried, and the product retained at the origin (1 inch strip) was
determined by liquid scintillation counting in Scinti Verse I.
Assay of Soluble and Membrane-associated Polysaccharide
Products--
Isolated membranes containing 300 µg of total protein
were added to reactions containing 100 mM Hepes (pH 8), 10 mM sodium thioglycolate, 10 mM
MnCl2, UDP-Glc, and UDP-GlcUA in a 600-µl volume. The
reactions were incubated at 32 °C, and, at the times indicated in
the figure legends, 50-µl samples were taken. These aliquots were
submitted to the following protocol to determine the amount of soluble
and membrane-associated polysaccharide formed under various
experimental conditions. EDTA was added to the aliquots to a final
concentration of 10 mM, and the samples were stored on ice.
The volume was adjusted to 200 µl with 100 mM Hepes (pH 8) buffer containing 10 mM sodium thioglycolate. The
membranes were collected by centrifugation at 100,000 × g for 30 min. The supernatants were saved, and the pellets
were suspended in 200 µl of the same buffer. The membranes were
sedimented again by centrifugation at 100,000 × g for
30 min. The resulting supernatants were combined with the previous
supernatants, and the pellets were suspended in 400 µl of the same
buffer. Aliquots of the supernatant and pellet fractions were
chromatographed on paper as described above for the synthase assay. The
radioactivity at the origin, as well as that corresponding to authentic
UDP-Glc, was determined by liquid scintillation counting.
Sepharose 2B Column Chromatography--
Gel filtration of
polysaccharide samples was performed on a 1.4 × 37 cm Sepharose
2B column equilibrated with 0.2 M NaCl and 5 mM
Tris acetate (pH 7.4). SDS was added to the sample to a final concentration of 2% (v/v) prior to application to the column. The
column flow rate was 16 ml/h, and 1-ml fractions were collected. The
void and total volumes were determined using 0.798-µm diameter latex
beads (Sigma) and [14C]Glc, respectively. Polysaccharide
that eluted between 18 and 30 ml on Sepharose 2B is referred to as high
molecular weight.
Paper Chromatography--
The components of the hydrolysates
were separated by ascending paper chromatography in ethanol (95%)/1
M ammonium acetate (pH 7), 7:3 (v/v) or 1-propanol/ethyl
acetate/water, 7:1:2 (v/v/v). The chromatograms were cut into 1-cm
strips, and radioactivity was measured by liquid scintillation
counting. Monosaccharide standards were visualized using
p-anisidine-phthalate (27).
Chromatography on a Monoclonal Antibody Sepharose
Column--
Type 3 polysaccharide-specific monoclonal antibody 16.3 (28) was coupled to Sepharose 2B as described (29). The
antibody-conjugated beads (0.5-1 ml) were packed into 2-ml columns and
washed with 10 column volumes of 5 mM Tris acetate buffer
(pH 7.4) containing 0.2 M NaCl. Labeled polysaccharide was
applied to the column, and the column was washed with the same buffer.
Three 1.5-ml samples were collected, and 100 µl of each fraction was
chromatographed on paper as described for the assay of synthase
activity. The percentage of radioactive polysaccharide that bound to
the column was determined as 100 × [(total counts applied Purification of Polysaccharide on a Monoclonal Antibody Sepharose
Column--
Labeled polysaccharide that bound to the antibody affinity
column described above was eluted with 0.05 M glycine (pH
2.5) buffer containing 0.1% Triton X-100 and 0.15 M NaCl.
Seven 1-ml fractions were collected in tubes containing 100 µl of
Tris-HCl (pH 9.0). A portion (100 µl) of each fraction was
chromatographed on paper as described for the synthase assay, and
column fractions that contained labeled polysaccharide were pooled.
Preparation of Type 3 Polysaccharide-specific
Depolymerase--
The type 3 polysaccharide-specific depolymerase was
isolated from Bacillus circulans (ATCC 14175) using a
modification of a previously described procedure (30). Briefly, a 5-ml
culture of B. circulans was grown to mid exponential phase
in THY, diluted 1/5 in fresh THY, and incubated for 20 min at 37 °C.
Expression of the depolymerase by B. circulans was induced
by the addition of 50 µl of heat killed type 3 S. pneumoniae strain WU2, grown to late exponential phase,
centrifuged, and concentrated 30-fold in THY. A second inoculum (50 µl) of WU2 was added after 60 min, and the B. circulans
culture was incubated at 37 °C for an additional 60 min. The cells
were then heat killed at 65 °C for 20 min and sedimented for 2 min
at 13,000 × g, and the supernatant was collected and
stored at Preparation of Labeled Polysaccharide for Direction of Growth
Experiments--
For preparation A, uniformly labeled polysaccharide
membranes (300 µg of total protein) were incubated in a 200-µl
reaction containing 100 mM Hepes (pH 8), 10 mM
sodium thioglycolate, 10 mM MnCl2, 400 µM UDP-GlcUA, and 400 µM UDP-Glc (7 mCi/mmol) for 30 min at 32 °C. The reaction was terminated by the
addition of 10% SDS to a final concentration of 2% and
chromatographed on Sepharose 2B as described above. For preparation B,
terminally labeled polysaccharide membranes (1.5 mg of total protein)
were incubated in a 1-ml reaction containing 100 mM Hepes
(pH 8), 10 mM sodium thioglycolate, 10 mM
MnCl2, 400 µM UDP-GlcUA, and 400 µM UDP-Glc for 30 min at 32 °C. The reaction mixture
was placed on ice, and 1 ml of ice-cold 100 mM Hepes (pH
7.5) containing 10% glycerol was added. The membranes in the reaction
mixture were sedimented by centrifugation at 100,000 × g for 30 min. The pelleted membranes were suspended in 2 ml
of 100 mM Hepes (pH 7.5) containing 10% glycerol and
sedimented as above. The membranes were washed four more times using
this procedure. The washed membranes were incubated in a 1-ml reaction
containing 100 mM Hepes (pH 8), 10 mM sodium
thioglycolate, 10 mM MnCl2, and 2 µM UDP-Glc (287 mCi/mmol) for 30 min at 32 °C. The
reaction was terminated by the addition of 10% SDS to a final
concentration of 2% and then chromatographed on Sepharose 2B as
described above. For preparation C, low molecular weight terminally
labeled polysaccharide membranes (1.5 mg of total protein) were
incubated in a 1-ml reaction containing 100 mM Hepes (pH
8), 10 mM sodium thioglycolate, 10 mM
MnCl2, and 2 µM UDP-Glc (287 mCi/mmol) at
32 °C for 10 min. The reaction was sonicated for 1 min in a
sonicating water bath at 80 watts (Ultrasonics, Plainview, NY) to
release the polysaccharide from the membrane. The insoluble material
was removed by centrifugation at 100,000 × g for 30 min. The soluble polysaccharide was purified by chromatography on
antibody-Sepharose 2B as described above.
Enzyme Treatments--
Disaccharide produced by partial acid
hydrolysis was treated with Type VIII-A Protein Determinations--
Protein concentrations were
determined using the micro protein determination kit from Sigma.
Characterization of Type 3 Synthase Activity--
Membranes were
isolated from the type 3 S. pneumoniae strain WU2 and from
an isogenic derivative (JD908) that is nonencapsulated because of an
insertion mutation in cps3S. Synthase activity was determined by measuring the incorporation of 14C from
UDP-[14C]Glc into polysaccharide. Membranes from the
parent strain incorporated 15,301 cpm, whereas membranes from the
mutant strain, under identical assay conditions, incorporated 31 cpm
(data not shown). These data confirmed that Cps3S is the critical
enzyme responsible for the activity measured in this assay and that
incorporation of label does not occur in the absence of type 3 polysaccharide synthesis.
The activity of the parent type 3 synthase was characterized by
measuring the incorporation of 14C from both
UDP-[14C]Glc and from UDP-[14C]GlcUA into
capsular polysaccharide. Formation of 14C-labeled product
using membranes isolated from the parent strain was linear with time
for up to 30 min and was proportional to protein concentration.
Incorporation of [14C]Glc or [14C]GlcUA in
the absence of the other substrate was <5% that observed when
substrates were at equal concentrations. The synthase was active in the
presence of Mn2+ and Mg2+, with the highest
level of activity observed with 5-20 mM Mn2+
(Fig. 1). The optimal pH for the synthase
was between 8 and 8.5 in a reaction mixture containing either 10 mM Mn2+ or 10 mM Mg2+
(data not shown). The apparent Km values for both
UDP-Glc and UDP-GlcUA were lower in the presence of Mn2+
than with Mg2+ (Table I).
Characterization of the Polysaccharide Product--
Polymer
synthesized in a 2-h incubation with a high concentration (400 µM) of both UDP sugars eluted in the excluded volume of a
Sepharose 2B column (data not shown). Polysaccharide labeled with
UDP-[14C]Glc was completely hydrolyzed by 4 N
HCl to [14C]Glc in 2 h at 100 °C (Fig.
2A). Polysaccharide labeled
with UDP-[14C]GlcUA was completely hydrolyzed to
[14C]GlcUA and GlcUA-lactone under the same conditions
(Fig. 2B). The presence of Glc and GlcUA in the polymer was
confirmed by chromatography in a second solvent containing
1-propanol/ethyl acetate/water, 7:1:2 (data not shown). Hydrolysis in 1 N HCl of both [14C]Glc- and
[14C]GlcUA-labeled polysaccharide resulted in the
liberation of both monosaccharides, as well as a product that migrated
between 6 and 11 cm from the origin, suggestive of a disaccharide (Fig. 2, A and B). Mild hydrolysis of polysaccharides
containing GlcUA readily yields aldobiouronic acids because of the
strong resistance of the uronidic linkage to hydrolysis with acids
(31). When the putative disaccharide was digested with
exo-
Additional evidence for the identity of the polysaccharide was obtained
by digestion of the high molecular weight polysaccharide with a type 3 polysaccharide-specific depolymerase from B. circulans. This
enzyme is highly specific for type 3 polysaccharide and has been shown
to hydrolyze the
A monoclonal antibody specific for type 3 polysaccharide was coupled to
Sepharose 2B and shown to specifically bind the high molecular weight
polymer. Columns packed with 0.5 ml of the antibody-conjugated beads
bound 99% of both the [14C]Glc-labeled and the
[14C]GlcUA-labeled high molecular weight products (data
shown in Fig. 4 for the Glc-labeled
product). The addition of unlabeled type 3 polysaccharide added along
with the labeled polysaccharide resulted in a
concentration-dependent inhibition of binding of the
[14C]Glc-labeled polymer (Fig. 4). No inhibition was
observed when unlabeled type 1 polysaccharide was added. All of these
results confirmed that the isolated product had the expected properties of authentic type 3 polysaccharide.
Polysaccharide Chain Elongation and Release--
Pulse-chase
experiments with the type 3 synthase showed that low molecular weight
polysaccharide labeled in a 3-min pulse could be chased after 20 min
into high molecular weight chains that eluted near the excluded volume
of a Sepharose 2B column (Fig. 5). A
polysaccharide of intermediate length was observed after a 5-min chase.
These results are suggestive of a processive biosynthetic mechanism,
whereby the elongating polysaccharide chain remains associated with the
enzyme-membrane complex.
To further evaluate the mechanism of the synthase reaction, we
investigated the association of polysaccharide with the enzyme complex
during the course of synthesis. Reaction mixtures containing 100 µM UDP-Glc and 200 µM UDP-GlcUA were
sampled during a 60-min incubation and sedimented by centrifugation to
separate the soluble polysaccharide from the membrane-associated
polysaccharide. There was a steady increase in the incorporation of
[14C]Glc into membrane-associated polysaccharide during
the first 30 min of incubation, whereas only a small fraction (12.4%)
was incorporated into soluble polysaccharide (Fig.
6A). By 60 min, the fraction
of radioactivity found as soluble polysaccharide had increased to 35%,
whereas the amount found as membrane-associated polysaccharide had
begun to decrease, suggesting that the membrane-associated product
might be a precursor to the soluble polymer.
At lower concentrations of UDP-Glc and UDP-GlcUA (2 and 20 µM, respectively), the incorporation of Glc into
membrane-associated polysaccharide reached a maximum by 5 min and then
declined rapidly so that by 30 min approximately equal amounts of label
were found in the soluble and membrane-associated fractions. Again, Glc
was initially incorporated into membrane-associated polymer, which was
subsequently released as a soluble form. The soluble and membrane associated polysaccharides obtained under a variety of conditions were
analyzed by Sepharose 2B chromatography. Similar size profiles were
observed for both fractions, indicating that release of the polysaccharide from the membrane was independent of the size of the
polymer (data not shown).
Although size did not appear to be a factor in polysaccharide release,
the increase in the soluble form of polysaccharide in Fig. 6 coincided
with the depletion of UDP-Glc. To further examine the effect of
substrate concentration on polysaccharide release, a series of
reactions were performed as in Fig. 6B above, except that
additional substrate was added 5 min after initiating the reaction. As
shown in Fig. 7, the simultaneous
addition of both substrates prolonged the association of the
polysaccharide with the membrane (Fig. 7A), whereas the
separate addition of either UDP-Glc or UDP-GlcUA markedly stimulated
the appearance of soluble polymer (Fig. 7, B and
C). These data suggest that polysaccharide release may be
enhanced when one substrate is limiting. Polysaccharide release was not
due to the generation of free UDP during polysaccharide synthesis,
because the addition of 1 mM UDP did not stimulate release
(Fig. 7D).
Direction of Chain Growth--
To determine whether sugar addition
occurs at the reducing or nonreducing end of the type 3 polysaccharide,
polymer was labeled with [14C]Glc either uniformly
(preparation A) or on the terminus of the growing end (preparation B).
Both methods of preparing polysaccharide resulted in a radioactive
product that eluted near the void volume of a Sepharose 2B column as
well as a peak of radioactivity that corresponded to UDP-Glc (Fig.
8A). The polysaccharide
product obtained by both of the methods was degraded by the type 3 polysaccharide-specific depolymerase (Fig. 8B). Digestion
with the depolymerase confirmed that both labeled products were indeed
type 3 polysaccharide. Digestion of the terminally labeled
polysaccharide with an exo-
Terminally labeled polysaccharide was also made by incubating membranes
with UDP-[14C]Glc in the absence of UDP-GlcUA and without
any initial elongation with unlabeled substrates (preparation C). This
procedure yielded labeled polysaccharide that bound to an affinity
column made with monoclonal antibodies to type 3 polysaccharide.
Exo- The type 3 synthase of S. pneumoniae belongs to a
family of processive We have shown here that the type 3 synthase in S. pneumoniae
membrane preparations is optimally active in the presence of Mn2+. Furthermore we have shown that the apparent
Km values for both UDP-Glc and UDP-GlcUA are lower
in the presence of Mn2+ than in Mg2+. In our
standard assay, no significant incorporation of Glc from UDP-Glc
occurred in the absence of UDP-GlcUA, and no incorporation of GlcUA
from UDP-GlcUA occurred in the absence of UDP-Glc. These data are in
agreement with the expected catalytic properties for the formation of a
polymer containing alternating glucosyl and glucuronosyl residues. The
product was shown to be composed of Glc and GlcUA, and could be
degraded by a type 3 polysaccharide specific-depolymerase. Furthermore,
the polymer bound specifically to an affinity column made with a
monoclonal antibody to type 3 polysaccharide, and no activity was
observed with membranes from strains containing an insertion mutation
in cps3S. We confirmed the presence of The type 3 synthase is capable of rapidly forming both glycosidic
linkages of type 3 polysaccharide to polymerize UDP-Glc and UDP-GlcUA
into high molecular weight polysaccharide. We have shown that the
polysaccharide remained associated with the membrane-enzyme complex
during elongation, indicating a processive mechanism. Theoretically the
addition of Glc and GlcUA to type 3 polysaccharide could occur from
either the reducing or nonreducing end. The direction of chain
elongation catalyzed by hyaluronan synthases has been debated for a
number of years. Stoolmiller and Dorfman (36) demonstrated convincingly
in 1969 that the direction of hyaluronic acid chain growth in S. pyogenes occurs by the addition of monosaccharide units
to the nonreducing end of endogenous polysaccharide. The results of
this investigation were, however, largely obscured by the subsequent
finding of dolichol-linked disaccharides and oligosaccharides
containing GlcUA and GlcNAc (37, 38) and particularly by the report
that hyaluronate chain growth occurs at the reducing end in
teratocarcinoma cells (39, 40). Correspondingly, the model of Saxena
et al. (23) indicated that growth of hyaluronic acid, as
well as several other In our experiments determining the direction of growth, we observed
that S. pneumoniae membranes contain nascent polysaccharide that can be labeled with Glc from UDP-Glc without the addition of
UDP-GlcUA. The presence of type 3 polysaccharide in membrane preparations of S. pneumoniae (3) and our results showing
that polysaccharide terminally labeled with Glc specifically binds to
an affinity column made with monoclonal antibodies to type 3 polysaccharide indicate that pre-existing type 3 polysaccharide serves
as an acceptor in these experiments. Because our membrane preparations
contain preformed polysaccharide acceptor, we are unable to determine
whether the type 3 synthase is capable of de novo synthesis
from the nucleotide sugars or whether some of form of primer is
required. However, the recent expression of a related
glycosyltransferase in S. cerevisiae (20) could provide a
means to answer this question because this organism does not make
UDP-GlcUA.
The growth of type 3 polysaccharide at the nonreducing end and the
synthesis by a processive mechanism suggests that the growing polymer
is bound to the enzyme via a site that recognizes the terminal sugar(s)
of the nonreducing end. Examination of the association of type 3 polysaccharide with the membrane-enzyme complex indicated that the
interaction of the polysaccharide chain with the enzyme is affected by
the UDP sugar concentrations. We found that when both substrates are in
excess, the polysaccharide chain remained associated with the
membrane-enzyme complex. However, a portion of the polysaccharide was
released from the membrane-enzyme complex when the level of one of the
substrates became limiting and was stimulated when one UDP substrate
was added in excess. That this effect occurred at the point of
substrate depletion suggests that the presence of a single substrate
may stimulate release. Prehm (40) also observed a slow but distinct
shedding of pulse-labeled hyaluronate when one obligatory component,
such as MgCl2, UDP-GlcNAc, or UDP-GlcUA, was omitted during
the chase period. This release of hyaluronan was shown to be
independent of size (40), an observation that we have also made for
type 3 polysaccharide. The selective inhibition of hyaluronate chain
release, but not elongation, by p-chloromercuribenzoate
prompted the suggestion that the release process might be an enzymatic
mechanism (43). Current experiments examining the effect of a single
substrate on type 3 polysaccharide release have shown that the release
is dependent on time, temperature, and the concentration of the
UDP-monomer,2 also suggesting
an enzymatic mechanism.
In summary, the data presented here provide an in-depth
characterization of the type 3 synthase involved in the synthesis of
pneumococcal capsule. The demonstration of growth of type 3 polysaccharide from the nonreducing end, as well as a potential mechanism of polysaccharide release, provides new information on the
mechanism of type 3 polysaccharide synthesis as well as other
-D-GlcUA-(1
4)-
-D-Glc-(1
]n) are formed by the membrane-associated type 3 synthase (Cps3S), which is
capable of synthesizing polymer from UDP sugar precursors. Using
membrane preparations of S. pneumoniae in an in
vitro assay, we observed type 3 synthase activity in the presence
of either Mn2+ or Mg2+ with maximal levels seen
with 10-20 mM Mn2+. High molecular weight
polymer synthesized in the assay was composed of Glc and glucuronic
acid and could be degraded to a low molecular weight product by a type
3-specific depolymerase from Bacillus circulans.
Additionally, the polymer bound specifically to an affinity column made
with a type 3 polysaccharide-specific monoclonal antibody. The
polysaccharide was rapidly synthesized from smaller chains and remained
associated with the enzyme-containing membrane fraction throughout its
synthesis, indicating a processive mechanism of synthesis. Release of
the polysaccharide was observed, however, when the level of one of the
substrates became limiting. Finally, addition of sugars to the growing
type 3 polysaccharide was shown to occur at the nonreducing end of the
polysaccharide chain.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
3)-
-D-GlcUA-(1
4)-
-D-Glc-(1
] repeating units (4). Two other genes, cps3U, encoding a
Glc-1-P uridylyltransferase, and cps3M, encoding a homologue
of phosphoglucomutases, are present in the type 3-specific locus. These
sequences are not essential for type 3 capsule synthesis, however,
because the functions they encode are duplicated by other genes in the
pneumococcal chromosome (3, 5, 6). Flanking either side of the
type-specific genes are sequences common to all capsule types (7-11).
These common genes have been proposed to play a role in polysaccharide transport and in determination of polysaccharide chain length in some
capsular polysaccharides. In type 3 strains, however, most of these
sequences are mutated and are not required for polysaccharide synthesis
or transport (3, 5, 12). No other sequences likely to be involved in
transport of the type 3 polysaccharide have been identified, and this
function may be performed by the type 3 synthase.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-glucuronidase from
E. coli,
-glucosidase from Caldocellum
sachrolyticum, Sepharose 2B, UDP-Glc, and UDP-GlcUA were obtained
from Sigma. UDP-[14C]Glc (257 mCi/mmol) and
UDP-[14C]GlcUA (287 mCi/mmol) were obtained from Andotek.
Todd Hewitt Broth and yeast extract were from Difco. Type 1 and type 3 polysaccharides were from the American Type Culture Collection. Scinti
Verse I was obtained from Fisher.
20 °C.
recovered counts)/total counts].
70 °C.
-glucuronidase (27, 800 units/ml) at 37 °C for the times indicated. Digestion of
polysaccharide with
-glucosidase was performed in a 100-µl
reaction containing 0.1 M sodium acetate (pH 5.0) and
-glucosidase (3 units/ml) at 37 °C for the times specified.
Experiments using the type 3 polysaccharide-specific depolymerase from
B. circulans (purification described above) were performed
in 20 mM MES buffer (pH 6.5) containing 0.2% sodium azide
at 37 °C for the length of time specified.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (15K):
[in a new window]
Fig. 1.
The effect of metal ion concentration on
Cps3S activity. Membranes (3 µg of total protein) from type 3 S. pneumoniae were incubated at 32 °C for 20 min in a
100-µl reaction containing 100 mM Hepes (pH 8), 10 mM sodium thioglycolate, 2 µM UDP-Glc (257 mCi/mmol), 20 µM UDP-GlcUA, and increasing amounts of
MnCl2 (
), MgCl2 (
), or CaCl2
(
). The product was separated by paper chromatography as described
under "Experimental Procedures," and the radioactivity was
determined by liquid scintillation counting. The amount of
radioactivity in a sample that contained no metal ion was subtracted as
background. Each point is the average of duplicate samples. Activity
was determined as nmol of 14C/mg of total protein/h
incorporated into polysaccharide.
The effect of metal ion on Michaelis-Menton constants
-glucuronidase, 75% of the radioactivity was liberated as free
glucose (Fig. 2C). These results confirmed the presence of a
-glucuronidic linkage and are consistent with the slower migrating
product being the disaccharide GlcUA-
-Glc.

View larger version (25K):
[in a new window]
Fig. 2.
Acid hydrolysis of [14C]Glc-
and [14C]GlcUA-labeled polysaccharide.
Polysaccharide labeled with [14C]Glc was prepared as
described in the legend to Fig. 1 except that a 2-ml reaction mixture
containing 3 mg of protein and 10 mM MnCl2 was
used. The reaction was incubated for 10 min at 32 °C. UDP-Glc and
UDP-GlcUA were added to a final concentration of 400 µM
each, and incubation was continued for an additional 2 h.
Polysaccharide was separated from unincorporated UDP sugars by
Sepharose 2B column chromatography, and fractions 18-30 were pooled
and concentrated 6-fold on Amicon YM10 ultrafiltration membranes.
[14C]GlcUA-labeled polysaccharide was prepared in the
same manner except that 14 µM UDP
[14C]GlcUA (287 mCi/mmol) and 100 µM
UDP-Glc were used in the initial reaction. 100-µl aliquots of
[14C]Glc-labeled polysaccharide (5000 cpm) (A)
and [14C]GlcUA-labeled polysaccharide (9000 cpm)
(B) were hydrolyzed with 4 (
), 1 (
), or 0 N HCl (
) at 100 °C for 2 h. The hydrolysis
products were separated by paper chromatography in ethanol (95%)/1
M ammonium acetate (pH 7), 7:3, and the radioactivity
present in 1-cm strips was determined by liquid scintillation counting
and expressed as a percentage of the total cpm. C, a
400-µl sample of the [14C]Glc-labeled polymer was
hydrolyzed in 1 N HCl and chromatographed as described for
A. The radioactivity present between 6 and 11 cm on the
chromatogram was eluted in water. The eluted product was treated with
3475 units of
-glucuronidase for 2 days at 37 °C. An untreated
sample (
) and the treated sample (
) were chromatographed as
above. The locations of standard Glc, GlcUA, and GlcUA-lactone are
indicated on the graph.
1,4 linkages of this polymer to yield oligosaccharides with an average length of a tetrasaccharide (30). Following treatment with the depolymerase for 48 h, the high
molecular weight [14C]Glc-labeled polysaccharide was
degraded to a lower molecular weight product as determined by
chromatography on Sepharose 2B (Fig. 3).
Identical results were obtained using [14C]GlcUA-labeled
polysaccharide (data not shown).

View larger version (12K):
[in a new window]
Fig. 3.
Degradation of high molecular weight product
by a type 3 polysaccharide-specific depolymerase. High molecular
weight [14C]Glc-labeled polysaccharide (8400 cpm),
synthesized as in Fig. 2, was incubated in 20 mM MES buffer
(pH 6.0) with 100 µl of the depolymerase preparation for 48 h at
37 °C. Untreated (
) and treated (
) samples were
chromatographed on Sepharose 2B. The amount of radioactivity present in
the even-numbered fractions was determined. A background of 20 cpm was
subtracted from each fraction.

View larger version (14K):
[in a new window]
Fig. 4.
Specific binding of product to a type 3 polysaccharide-specific monoclonal antibody column. High molecular
weight [14C]Glc labeled-polysaccharide (2300 cpm),
synthesized as in Fig. 2, was mixed with the indicated amounts of
either unlabeled type 3 polysaccharide (
) or unlabeled type 1 polysaccharide (
). The samples were applied to affinity columns made
with a monoclonal antibody to type 3 polysaccharide, and the percentage
of radioactivity that bound to the column was determined as described
under "Experimental Procedures."

View larger version (14K):
[in a new window]
Fig. 5.
Pulse-chase analysis of type 3 polysaccharide
synthesis. Membranes containing 300 µg of total protein were
incubated in 100 mM Hepes (pH 8), 10 mM sodium
thioglycolate, 10 mM MnCl2, 2 µM
UDP-Glc (257 mCi/mmol), and 20 µM UDP-GlcUA at 32 °C
in a 200-µl reaction. After 3 min, a 30-µl sample was removed,
UDP-Glc and UDP-GlcUA (400 µM each) were added, and
incubation was continued. 30-µl samples were then removed after 5 and
20 min of chase. The samples were brought to 500 µl in 100 mM Hepes buffer (pH 8.0), 10 mM sodium
thioglycolate, and 2% SDS. The pulse (
), 5 min chase (
), and 20 min chase (
) samples were then applied to a Sepharose 2B column, and
the amount of radioactivity present in the even numbered fractions was
determined. The values for each fraction are reported as the
percentages of the total radioactivity present in the sample. The void
and total volumes are indicated as Vi and
Vt, respectively.

View larger version (15K):
[in a new window]
Fig. 6.
Formation of soluble and membrane-associated
polysaccharide. Reactions containing 100 µM UDP-Glc
(5 mCi/mmol) and 200 µM UDP-GlcUA (A) or 2 µM UDP-Glc (257 mCi/mmol) and 20 µM
UDP-GlcUA (B) were prepared as described under
"Experimental Procedures." Samples (50 µl) were taken after 0, 5, 10, 30, and 60 min of incubation, and the soluble and
membrane-associated polysaccharides were separated as described under
"Experimental Procedures." The amount of radioactivity present as
soluble polysaccharide (
), membrane-associated polysaccharide (
),
and unincorporated UDP-[14C]Glc (
) was determined
after ascending paper chromatography in ethanol/1 M
ammonium acetate (pH 7.0), 7:3 as a percentage of the total
radioactivity.

View larger version (22K):
[in a new window]
Fig. 7.
The effect of substrate on polysaccharide
release. Reactions were performed as described for Fig.
6B, except the following additions were made after 5 min of
incubation (see arrow). A, 400 µM
of both UDP-Glc and UDP-GlcUA; B, 400 µM
UDP-GlcUA; C, 400 µM UDP-Glc; D, 1 mM UDP. The radioactivity present as soluble (
) and
membrane-associated (
) polysaccharide was determined as described
under "Experimental Procedures." The rate of UDP-Glc depletion was
similar to that shown in Fig. 6B.
-glucosidase for 24 h liberated
72.8% of the counts as [14C]Glc, whereas uniformly
labeled polysaccharide yielded undectable levels of
[14C]Glc after digestion with exo-
-glucosidase (Fig.
8C). The degradation of the terminally labeled
polysaccharide with exo-
-glucosidase was time-dependent
(Fig. 8D). Because exo-
-glucosidase removes only the
terminal Glc residues from the nonreducing end of the polysaccharide,
these data demonstrate that type 3 polysaccharide growth occurs from
the nonreducing end.

View larger version (21K):
[in a new window]
Fig. 8.
Direction of type 3 polysaccharide
growth. Polysaccharide was labeled either uniformly (
,
preparation A) or terminally (
, preparation B) with
[14C]Glc as described under "Experimental
Procedures." A, the labeled polysaccharides were
chromatographed on Sepharose 2B, and the amount of radioactivity in the
even-numbered fractions was determined. B, fractions (18-30
ml) containing the high molecular weight polysaccharide were pooled and
concentrated 10-fold by filtration on Amicon YM10 ultrafiltration
membranes followed by ethanol precipitation. An aliqout of each
polysaccharide was treated with 100 µl of depolymerase for 72 h
and then chromatographed on Sepharose 2B. The amount of radioactivity
found in the even numbered fractions was determined. C,
samples of both polysaccharides were treated for 24 h with 1.5 units of exo-
-glucosidase. The digestions were chromatographed in
ethanol (95%)/1 M ammonium acetate (pH 7.0), 7:3, and the
amount of radioactivity present in successive 1 cm strips was
determined as a percentage of the total radioactivity present in all
the strips. A background of 20 cpm was subtracted from each strip. The
location of Glc on the chromatogram is indicated on the graph.
D, samples of both polysaccharides were treated with 1.5 units of exo-
-glucosidase for the times indicated on the graph. The
digestions were chromatographed as in C, and the amount of
radioactivity present as Glc was determined as a percentage of the
total radioactivity found at the origin and as Glc.
-glucosidase treatment of polysaccharide eluted off the affinity
column released 75.4% of the counts as [14C]Glc (data
not shown). This result further supports growth of type 3 polysaccharide from the nonreducing end. Furthermore, the incorporation
of Glc in the absence of UDP-GlcUA into a product that bound to a type
3 polysaccharide-specific antibody, supports the presence of preformed
type 3 polysaccharide acceptor in S. pneumoniae membranes.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-glycosyltransferases whose members include the
hyaluronic acid synthases from S. pyogenes and
X. laevis, the Nod factor synthase from Rhizobium
sp., chitin synthases from C. albicans and S. cerevisiae, RfbB-0:54 from Salmonella enterica, and the cellulose synthases from bacteria and plants. All of these enzymes catalyze the formation of all the glycosidic linkages of their respective polysaccharides and are thought to function via a similar mechanism (22, 23). The
-glycosidic linkages of the polysaccharides synthesized by these enzymes are derived from UDP sugar precursors, which are linked in the
configuration. By analogy with the
extensively characterized glycosyl hydrolase systems, these enzymes
would be expected to provide for an inverting mechanism during polymer formation (32). A model has recently been proposed for a mechanism of
polymerization for the family of processive
-glycosyltransferases that would allow for the simultaneous or consecutive formation of two
-glycosidic linkages (23). Hydrophobic clustering analysis of the
enzymes in this family showed two conserved domains, each of which is
believed to be capable of binding a nucleotide sugar and catalyzing the
formation of a glycosidic linkage (22, 23). Because polysaccharides
like chitin, cellulose, and hyaluronic acid adopt a 2-fold screw axis
(33-35), this model proposed that the binding sites for each of the
nucleotide sugars are oriented 180° in regard to one another, thus
allowing such polysaccharides to be generated without rotating either
the enzyme or the polysaccharide (23). The loss of two UDP molecules
from the catalytic site after addition of the two monosaccharides has
been proposed to provide the necessary energy to translocate the
polymer and allow two more nucleotide sugars to bind (23).
-linkages by
demonstrating sensitivity to both an exo-
-glucosidase and an
exo-
-glucuronidase. All of these properties are consistent with the
product being type 3 polysaccharide.
-glycans, occurred from the reducing end. We
have shown, however, that approximately 75% of labeled Glc added to
the growing end of type 3 polysaccharide chains can be removed by an
exo-
-glucosidase, indicating that type 3 polysaccharide grows from
the nonreducing end. Recent reports on the direction of chain growth
for cellulose in Cladaphora and Acetobacter (41) and hyaluronate in P. multocida (42) have also indicated
that growth occurs from the nonreducing end. Whether all the members of
the family of processive
-glycosyltransferases synthesize their
polysaccharides from the nonreducing end, as suggested by Koyama
et al. (41), remains to be determined.
-glycans synthesized by related enzymes.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Joseph Dillard for preparing the type 3 polysaccharide-specific depolymerase and John Baker for helpful comments on the manuscript.
| |
FOOTNOTES |
|---|
* This work was supported by Public Health Service Grants GM53017 and T32HL07553.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of
Microbiology, BBRB 661/12,845 19th St. S., University of Alabama at
Birmingham, Birmingham, AL 35294. Tel.: 205-934-9531; Fax:
205-975-6715; E-mail: jyother@uab.edu.
2 W. T. Forsee, R. T. Cartee, and J. Yother, manuscript in preparation.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: Cps3S, type 3 synthase; GlcUA, glucuronic acid; MES, 2-(N-morpholino)ethanesulfonic acid.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Henrichsen, J. (1995) J. Clin. Microbiol. 33, 2759-2762[Abstract] |
| 2. | Van Dam, J. E., Fleer, A., and Snippe, H. (1990) Antonie Van Leeuwenhoek 58, 1-47[CrossRef][Medline] [Order article via Infotrieve] |
| 3. |
Dillard, J.,
Vandersea, M.,
and Yother, J.
(1995)
J. Exp. Med.
181,
973-983 |
| 4. |
Reeves, R.,
and Goebel, W.
(1941)
J. Biol. Chem.
139,
511-517 |
| 5. | Caimano, M. J., Hardy, G. G., and Yother, J. (1998) Microb. Drug Resist. 4, 11-23[Medline] [Order article via Infotrieve] |
| 6. |
Mollerach, M.,
Lopez, R.,
and Garcia, E.
(1998)
J. Exp. Med.
188,
2047-2056 |
| 7. | Dillard, J., and Yother, J. (1994) Mol. Microbiol. 12, 959-972[CrossRef][Medline] [Order article via Infotrieve] |
| 8. |
Guidolin, A.,
Morona, J.,
Morona, R.,
Hansman, D.,
and Paton, J.
(1994)
Inf. Immun.
62,
5384-5396 |
| 9. | Munoz, R., Mollerach, M., Lopez, R., and Garcia, E. (1997) Mol. Microbiol. 25, 79-92[CrossRef][Medline] [Order article via Infotrieve] |
| 10. |
Kolkman, M.,
Morrison, D.,
van der Zeijst, B.,
and Nuijten, P.
(1996)
J. Bacteriol.
178,
3736-3741 |
| 11. |
Kolkman, M. A. B.,
van der Zeijst, B.,
and Nuijten, P. J. M.
(1997)
J. Biol. Chem.
272,
19502-19508 |
| 12. | Arrecubieta, C., Garcia, E., and Lopez, R. (1995) Gene (Amst.) 167, 1-7[CrossRef][Medline] [Order article via Infotrieve] |
| 13. |
Arrecubieta, C.,
Lopez, R.,
and Garcia, E.
(1996)
J. Exp. Med.
184,
449-455 |
| 14. |
DeAngelis, P. L.,
Papaconstantinou, J.,
and Weigel, P. H.
(1993)
J. Biol. Chem.
268,
14568-14571 |
| 15. |
DeAngelis, P. L.,
Papaconstantinou, J.,
and Weigel, P. H.
(1993)
J. Biol. Chem.
268,
19181-19184 |
| 16. | Bulawa, C., Slater, M., Cabib, E., Au-Young, J., Sburlati, A., Adair, W., and Robbins, P. (1986) Cell 46, 213-225[CrossRef][Medline] [Order article via Infotrieve] |
| 17. |
Geremia, R. A.,
Mergaert, P.,
Geelen, D.,
Montagu, M. V.,
and Holsters, M.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
2669-2673 |
| 18. | Chen-Wu, J. L., Zwicker, J., Bowen, A. R., and Robbins, P. W. (1992) Mol. Microbiol. 6, 497-502[CrossRef][Medline] [Order article via Infotrieve] |
| 19. |
Meyer, M.,
and Kreil, G.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
4543-4547 |
| 20. |
DeAngelis, P. L.,
and Achyuthan, A. M.
(1996)
J. Biol. Chem.
271,
23657-23660 |
| 21. |
Silakowski, B.,
Pospiech, A.,
Neumann, B.,
and Schairer, H. U.
(1996)
J. Bacteriol.
178,
6706-6713 |
| 22. |
Keenleyside, W. J.,
and Whitfield, C.
(1997)
J. Biol. Chem.
271,
28581-28592 |
| 23. |
Saxena, I., R.,
Brown, J.,
Fevere, M.,
Geremia, R.,
and Henrissat, B.
(1995)
J. Bacteriol.
177,
1419-1424 |
| 24. |
Smith, E.,
Mills, G.,
Bernheimer, H.,
and Austrian, R.
(1960)
J. Biol. Chem.
235,
1876-1880 |
| 25. |
Yother, J.,
and White, J.
(1994)
J. Bacteriol.
176,
2976-2985 |
| 26. |
Briles, D. E.,
Claflin, J. L.,
Schroer, K.,
Davie, J.,
Baker, P.,
Kearney, J.,
and Barletta, R.
(1981)
J. Exp. Med.
153,
694-705 |
| 27. | Zweig, G., and Whitaker, J. R. (1967) Paper Chromatography and Electrophoresis , Academic Press, New York |
| 28. | Briles, D. E., Claflin, J. L., Schroer, K., and Forman, C. (1981) Nature 294, 88-90[CrossRef][Medline] [Order article via Infotrieve] |
| 29. | Springer, T. A. (1993) in Current Protocols in Molecular Biology (Janssen, K., ed) , John Wiley & Sons, Inc., New York |
| 30. |
Torriani, A.,
and Pappenheimer, A.
(1962)
J. Biol. Chem.
237,
3-13 |
| 31. | Pigman, W. W., and Goepp, R. M. , J. (1948) Chemistry of Carbohydrates , Academic Press, New York |
| 32. | Sinnott, M. L. (1990) Chem. Rev. 90, 1171-1202[CrossRef] |
| 33. | Heatley, F., and Scott, J. E. (1988) Biochem. J. 254, 489-493[Medline] [Order article via Infotrieve] |
| 34. | Gardner, K. H., and Blackwell, J. (1974) Biopolymers 13, 1975-2001[CrossRef] |
| 35. | Minke, R., and Blackwell, J. (1978) J. Mol. Biol. 120, 167-181[CrossRef][Medline] [Order article via Infotrieve] |
| 36. |
Stoolmiller, A.,
and Dorfman, A.
(1969)
J. Biol. Chem.
244,
236-246 |
| 37. |
Turco, S. J.,
and Heath, E. C.
(1977)
J. Biol. Chem.
252,
2918-2928 |
| 38. | Hopwood, J. J., and Dorfman, A. (1977) Biochem. Biophys. Res. Commun. 75, 472-479[CrossRef][Medline] [Order article via Infotrieve] |
| 39. | Prehm, P. (1983) Biochem. J. 211, 191-198[Medline] [Order article via Infotrieve] |
| 40. | Prehm, P. (1983) Biochem. J. 211, 181-189[Medline] [Order article via Infotrieve] |
| 41. |
Koyama, M.,
Helbert, W.,
Imai, T.,
Sugiyama, J.,
and Henrissat, B.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
9091-9095 |
| 42. |
DeAngelis, P. L.
(1999)
J. Biol. Chem.
274 (37),
26557-26562 |
| 43. |
Sugahara, K.,
Schwartz, N. B.,
and Dorfman, A.
(1979)
J. Biol. Chem.
254,
6252-6261 |
This article has been cited by other articles:
![]() |
M. Belanova, P. Dianiskova, P. J. Brennan, G. C. Completo, N. L. Rose, T. L. Lowary, and K. Mikusova Galactosyl Transferases in Mycobacterial Cell Wall Synthesis J. Bacteriol., February 1, 2008; 190(3): 1141 - 1145. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Xayarath and J. Yother Mutations Blocking Side Chain Assembly, Polymerization, or Transport of a Wzy-Dependent Streptococcus pneumoniae Capsule Are Lethal in the Absence of Suppressor Mutations and Can Affect Polymer Transfer to the Cell Wall J. Bacteriol., May 1, 2007; 189(9): 3369 - 3381. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. C. Chang, A. Jong, S. Huang, P. Zerfas, and K. J. Kwon-Chung CPS1, a Homolog of the Streptococcus pneumoniae Type 3 Polysaccharide Synthase Gene, Is Important for the Pathobiology of Cryptococcus neoformans Infect. Immun., July 1, 2006; 74(7): 3930 - 3938. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. Forsee, R. T. Cartee, and J. Yother Role of the Carbohydrate Binding Site of the Streptococcus pneumoniae Capsular Polysaccharide Type 3 Synthase in the Transition from Oligosaccharide to Polysaccharide Synthesis J. Biol. Chem., March 10, 2006; 281(10): 6283 - 6289. [Abstract] |